| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.56 mm | 1.56 mm | 1.56 mm | 1.56 mm | 1.56 mm | 1.56 mm |
| Cash burn (monthly) | (no burn) | 225.36 k | 632.90 k | 588.00 k | 505.73 k | 416.74 k |
| Cash used (since last report) | n/a | 469.26 k | 1.32 mm | 1.22 mm | 1.05 mm | 867.78 k |
| Cash remaining | n/a | 1.09 mm | 245.62 k | 339.10 k | 510.41 k | 695.72 k |
| Runway (months of cash) | n/a | 4.9 | 0.4 | 0.6 | 1.0 | 1.7 |
| 13F holders | Current |
|---|---|
| Total holders | 18 |
| Opened positions | 9 |
| Closed positions | 4 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 357.92 mm |
| Total shares | 4.91 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Pardeep Nijhawan Medicine Professional | 2.59 mm | $2.28 mm |
| Lumira Capital Investment Management | 1.75 mm | $4.37 mm |
| Nijhawan Pardeep | 360.59 k | $1.15 mm |
| CM Management | 110.00 k | $184.80 mm |
| Citadel Advisors | 40.94 k | $69.61 mm |
| Geode Capital Management | 19.80 k | $33.67 mm |
| Vanguard | 15.86 k | $26.97 mm |
| Two Sigma Securities | 15.31 k | $25.73 mm |
| Tower Research Capital | 3.44 k | $5.78 mm |
| RY Royal Bank of Canada | 1.82 k | $3.00 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Feb 25 | Patrick Marshall | Common Shares | Grant | Acquire A | No | No | 1.92 | 41,666 | 80.00 k | 41,666 |
| 12 Feb 25 | Carlo Sistilli | Common Shares | Grant | Acquire A | No | No | 1.92 | 10,416 | 20.00 k | 10,416 |
| 12 Feb 25 | Nijhawan Pardeep | Series B-1 Convertible Preferred Shares Common Shares | Grant | Acquire A | No | No | 1.92 | 100 | 192.00 | 100 |
| 3 Feb 25 | Nijhawan Pardeep | Common Shares | Grant | Acquire A | No | No | 0 | 8,264 | 0.00 | 160,408 |
